✕

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Stocks Analysts Downgraded On Tuesday

Page 1 of 3

Stocks began the week with a sell-off. The S&P 500 fell 1.9% on Monday to 7,416.59. The pressure comes from interest rates. The Federal Reserve has raised them, and traders expect it to keep going.

The latest inflation report set the tone. The Bureau of Labor Statistics said consumer prices rose 0.4% in October, above the 0.3% economists expected, though below September’s 0.6% gain. Core prices, which leave out food and energy, rose 0.3% against a 0.2% forecast. Energy prices rose 0.7% in the month, food 0.5% and housing 0.3%.

Treasury yields jumped after the November 10 release. The 5-year yield rose 10 basis points to 4.75%, the 10-year rose 7 basis points to 4.93%, and the 30-year rose 3 basis points to 5.29%. Bets on a quarter-point rate hike in December stood at 84% that day, and bets on a half-point hike rose from 0% to 15%. Readers looking for cheaper names in a market like this can find more in our list of affordable stocks that Wall Street analysts like.

Goldman Strategists See a Reset in Tech Valuations

Not everyone is bearish. Peter Oppenheimer, who leads Goldman Sachs’ strategy team, and his colleagues forecast that the S&P 500 will climb 14% over the next 12 months to 8,700 points, even though the index is already up 11% in 2026. In a note reported on November 13, the call followed a 9% drop in the Nasdaq 100 from its early October high, driven by worries about the AI buildout.

The Goldman team says the biggest technology companies now trade well below their historical valuations, and it calls the group relatively defensive. It warns that those companies have turned cash-flow negative, though measures such as net debt to equity remain healthy. For stocks that analysts say have been sold too hard, see our list of oversold AI stocks where analysts see big upside.

The team expects earnings growth for S&P 500 companies to slow to 11% in 2027 from 36% in 2026, and growth for the Stoxx Europe 600 to slow to 7% from 18%. It is overweight US and Japanese stocks and underweight European ones, citing government debt issues and a heavy political calendar. It also favors industries that typically benefit from lower bond yields, easing inflation and falling oil prices. With growth slowing, Goldman expects investors to pay a premium for companies that can keep expanding quickly, and it sees opportunity in long-duration growth companies.

Photo by Arturo Añez on Unsplash

Our Methodology

To compile this list, we reviewed analyst rating downgrades announced on Tuesday, November 17, 2026. We have ranked these stocks in ascending order of their average upside potential, as of November 17.

At Insider Monkey, we are obsessed with what hedge funds do. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter strategy selects 14 small-cap and large-cap stocks every quarter and has returned 612% since May 2014, beating its benchmark by 375 percentage points (see more details here).

10 Stocks Analysts Downgraded On Tuesday

10. PepsiCo (NASDAQ:PEP)

Average Upside Potential: -1%

Bernstein cut PepsiCo to Underperform from Market Perform on November 17 and lowered its price target to $128 from $131. The firm expects the company to miss earnings per share expectations over the next 12 months because of weak results in North America, and it expects the stock’s multiple to shrink as investors accept that the company’s growth plan needs heavy catch-up spending.

PepsiCo makes and sells beverages, snacks and packaged foods, and Bernstein’s concerns sit in its two North American units. It expects Frito-Lay North America volumes to fall in 2027 as price investments lap and consumers keep buying fewer potato and tortilla chips. It also expects PepsiCo Beverages North America volumes to fall, with margins squeezed by inflation, higher advertising spending and the end of tariff benefits. Bernstein thinks productivity savings will not cover that gap. Bernstein expects international operations to offset part of the pressure but leave little room for error.

Bernstein also expects PepsiCo to keep losing market share as shoppers split between value and premium products, with limited pricing power. For the income side of the story, see our piece on whether PepsiCo’s dividend can hold up until a turnaround arrives.

9. Rapid Micro Biosystems (NASDAQ:RPID)

Average Upside Potential: 1%

Roth/MKM downgraded Rapid Micro Biosystems to Neutral from Buy on November 17 and lowered its price target to $0.75 from $3.00. The new target matches the price Merck KGaA, Darmstadt, Germany, agreed to pay in cash for each share, and the deal is expected to close in December 2026. A target set at the offer price leaves bulls with little to argue about, since the stock is now tied to the buyout.

Rapid Micro Biosystems sells automated systems that pharmaceutical manufacturers use to test products for microbial contamination. The business has been growing but has not yet reached profitability. Revenue rose 20.78% over the past 12 months, and revenue has grown 15.88% a year over the past five years. Operating margin over the past 12 months was -131.03%, which shows how far the company still is from covering its costs.

The deal builds on an existing partnership with MilliporeSigma, which covers distribution of the Growth Direct system, possible consumables sourcing benefits and joint development. Roth/MKM downgraded the stock because the buyout price now defines what shareholders can expect from it.

Page 1 of 3